ALZHEIMER’S DISEASE INTERNATIONAL LONDON LIMITED
Company number 13511752
- Company Overview for ALZHEIMER’S DISEASE INTERNATIONAL LONDON LIMITED (13511752)
- Filing history for ALZHEIMER’S DISEASE INTERNATIONAL LONDON LIMITED (13511752)
- People for ALZHEIMER’S DISEASE INTERNATIONAL LONDON LIMITED (13511752)
- More for ALZHEIMER’S DISEASE INTERNATIONAL LONDON LIMITED (13511752)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
14 Mar 2024 | AA | Total exemption full accounts made up to 30 June 2023 | |
28 Feb 2024 | AP01 | Appointment of Mr Nigel Ashley Jenner as a director on 22 February 2024 | |
13 Feb 2024 | TM01 | Termination of appointment of John Grosvenor as a director on 2 February 2024 | |
19 Dec 2023 | CH01 | Director's details changed for Mr John Grosvenor on 4 December 2023 | |
17 Dec 2023 | CH01 | Director's details changed for Mr Chris Lynch on 5 December 2023 | |
17 Dec 2023 | CH01 | Director's details changed for Mr Michael Lefevre on 4 December 2023 | |
07 Aug 2023 | CS01 | Confirmation statement made on 14 July 2023 with no updates | |
28 Apr 2023 | AA | Total exemption full accounts made up to 30 June 2022 | |
03 Feb 2023 | AD01 | Registered office address changed from 57a Great Suffolk Street London SE1 0BB United Kingdom to 15 Blue Lion Place London SE1 4PU on 3 February 2023 | |
02 Feb 2023 | AA01 | Previous accounting period shortened from 31 July 2022 to 30 June 2022 | |
30 Aug 2022 | CS01 | Confirmation statement made on 14 July 2022 with no updates | |
15 Jul 2021 | NEWINC |
Incorporation
Statement of capital on 2021-07-15
|